You just read:

DelMar Pharmaceuticals Delivers an Address and Presents an Overview of Upcoming GBM Trials with VAL-083 at the CNS Anticancer Drug Discovery Development Conference and Society for NeuroOncology Annual Meeting

News provided by

DelMar Pharmaceuticals, Inc.

Nov 21, 2016, 08:30 ET